Longevity

October 18, 2017

Natural product-based therapy for ageing-associated diseases: A therapeutic mix encompassing Lutein, Antacin C & Hesperidin (LAH), isolated from Kale, Antrodia cinnamomea, and Oranges, respectively, increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down regulation of its target gene, 19/October/2017, 1.49 am

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and […]
October 18, 2017

Lifespan extension therapy: Rivoglitazone, an anti-hyperglycemic drug,  may increase life span via up-regulation of its target gene BubR1, 19/October/2017, 1.21 am

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and […]
October 17, 2017

Life-extension therapy: Triptolide, isolated from Thunder God Vine,  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 17/October/2017, 10.52 pm

What they say: A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal […]
October 16, 2017

Lifespan extension therapy:  Glabridin, isolated from Licorice/Glycyrrhiza glabra L, which is used as a food additive (Sweetener),  increases life span via up-regulation of its target gene BubR1, 17/October/2017, 12.05 am

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and […]